Rome, Italy

Monica Binaschi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Monica Binaschi: Innovator in Pharmaceutical Combinations

Introduction

Monica Binaschi is a prominent inventor based in Rome, Italy. She has made significant contributions to the fields of immunology and molecular biology. With a total of 3 patents to her name, her work focuses on developing innovative pharmaceutical combinations for cancer treatment.

Latest Patents

Monica's latest patents include groundbreaking pharmaceutical combinations that comprise an anti-LY75 antibody. The first patent details pharmaceutical combinations that include antibodies directed against LY75, along with a second anti-cancer entity. This work aims to provide methods for treating diseases, particularly cancers mediated by LY75 expression or activity. Another patent focuses on pharmaceutical combinations that include antibodies against LY75 and Venetoclax, further enhancing treatment options for patients.

Career Highlights

Monica Binaschi is currently associated with Berlin-Chemie AG, where she continues to advance her research in pharmaceutical innovations. Her expertise in immunology has positioned her as a key figure in the development of new therapeutic strategies.

Collaborations

Monica has collaborated with notable colleagues such as Giuseppe Merlino and Mario Bigioni. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their field.

Conclusion

Monica Binaschi's contributions to pharmaceutical innovations demonstrate her commitment to advancing cancer treatment through her patented inventions. Her work continues to inspire and pave the way for future developments in immunology and molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…